Hallucinogen Persisting Perception Disorder Is a Psychedelics Problem Ehave Wants to Solve
“HPPD is a discomfort. Some people have it for 10, 15, 20 years and they regret the day they did the drug that caused it,” says the CEO of Ehave.
Day: September 13, 2021
UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials
“Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.
End of content
End of content